Abstract
Background
Factors of early and late recurrence after curative resection of hepatocellular carcinoma (HCC) may be different. The aim of this study was to identify clinical factors, including liver stiffness measurement (LSM), which are associated with HCC recurrence after curative resection.
Methods
Patients who underwent preoperative LSM and primary curative resection for HCC between October 2015 and May 2018 were retrospectively reviewed, with 1 year as the cut-off between early and late recurrence.
Results
Recurrence was observed in 42/149 (28.2%) patients over a median follow-up of 38.3 months (early recurrence: 10 [6.7%] patients; late recurrence: 32 [21.5%] patients). Multivariate analysis identified LSM (P = 0.026) and tumor size (P = 0.010) as the only factors that were significantly associated with recurrence-free survival. Compared with patients without recurrence, those with early recurrence had larger tumor size (P = 0.035) and those with late recurrence had higher LSM (P = 0.024). Receiver-operating characteristic analysis indicated that the optimal LSM cut-off value for predicting HCC recurrence was 7.4 kPa.
Conclusion
Tumor size was associated with early HCC recurrence after curative resection and LSM was associated with late recurrence. LSM cut-off of 7.4 kPa is recommended in predicting recurrence.
Similar content being viewed by others
References
Lupberger J, Hildt E (2007) Hepatitis B virus-induced cncogenesis. World J Gastroenterol 13:74–81
Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150:835–853
El-Serag HB, Marrero JA, Rudolph L et al (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134:1752–1763
Chen JA, Shi M, Li JQ et al (2010) Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatol Int 4:537–547
Tsai TJ, Chau GY, Lui WY et al (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608
Cha C, Fong Y, Jarnagin WR et al (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197:753–758
Nagano Y, Shimada H, Takeda K et al (2008) Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm. World J Surg 32:2218–2222
Sumie S, Kuromatsu R, Okuda K et al (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15:1375–1382
Lee S, Kang TW, Song KD et al (2019) (2019) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. https://doi.org/10.1097/SLA.0000000000003268
Sasaki Y, Imaoka S, Masutani S et al (1992) Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 112:515–521
Poon RT, Fan ST, Ng IO et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507
Yamamoto J, Kosuge T, Takayama T et al (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219–1222
Nagasue N, Uchida M, Makino Y et al (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105:488–494
Kim BK, Fung J, Yuen MF et al (2013) Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 19:1890–1900
Jung KS, Kim SU, Choi GH et al (2012) Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (Fibroscan®). Ann Surg Oncol 19:4278–4286
Jung KS, Kim JH, Kim SU et al (2014) Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model. PLoS ONE 9:1–7
Shimada M, Takenaka K, Taguchi K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80–85
Feo F, Pascale RM (2015) Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? Ann Transl Med 3:1–5
Arii S, Monden K, Niwano M et al (1998) Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 5:86–92
Hirokawa F, Hayashi M, Asakuma M et al (2016) Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma. Surg Oncol 25:24–29
Hong YM, Cho M, Yoon KT et al (2017) Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma. Tumor Biol 39:1–9
Portolani N, Coniglio A, Ghidoni S et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229–235
Shimoda M, Tago K, Shiraki T et al (2016) Risk factors for early recurrence of single lesion hepatocellular carcinoma after curative resection. World J Surg 40:2466–2471
Xin L, Haitao Z, Huayu Y et al (2009) A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol 100:488–493
Wu JC, Huang YH, Chau GY et al (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51:890–897
Cheng Z, Yang P, Qu S et al (2015) Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. HPB 17:422–427
Xing H, Zhang WG, Cescon M et al (2020) Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB 22:677–689
Zhou L, Rui JA, Wang SB et al (2013) Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 12:68–73
Sun HC, Zhang W, Qin LX et al (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47:684–690
Pan HW, Ou YH, Peng SY et al (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular cacinoma. Cancer 98:119–127
Shah SA, Greig PD, Gallinger S et al (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202:275–283
Meguro M, Mizuguchi T, Nishidate T et al (2015) Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World J Gastroenterol 21:4933–4945
Kim DY, Paik YH, Ahn SH et al (2007) PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 72:52–57
Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207
Du ZG, Wei YG, Chen KF et al (2014) Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients. Hepatobiliary Pancreat Dis Int 13:153–161
Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117
Cho A, Chung YE, Choi JS et al (2017) Feasibility of preoperative FDG PET/CT total hepatic glycolysis in the remnant liver for the prediction of postoperative liver function. Am J Roentgenol 208:624–631
Rajakannu M, Cherqui D, Ciacio O et al (2017) Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma. Surgery 162:766–774
Marcellin P, Ziol M, Bedossa P et al (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29:242–247
Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54
Wong VW, Vergniol J, Wong GL et al (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454–462
Nguyen-Khac E, Chatelain D, Tramier B et al (2008) Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 28:1188–1198
Akima T, Tamano M, Hiraishi H (2011) Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis. Hepatol Res 41:965–970
Masuzaki R, Tateishi R, Yoshida H et al (2009) Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49:1954–1961
Lee YR, Park SY, Kim SU et al (2017) Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol 32:1079–1086
Izumi T, Sho T, Morikawa K et al (2019) Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter. Hepatol Res 49:1207–1217
Jung KS, Kim SU, Ahn SH et al (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 53:885–894
Cho HJ, Kim B, Kim HJ et al (2020) Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Eur Radiol 30:4182–4192
Tabrizian P, Jibara G, Shrager B et al (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261:947–955
Funding
The authors of this manuscript have no conflicts of interest to disclose. The study received no grant support. The study was approved by the Institutional Review Board of the Seoul National University Hospital (No. H-1809–001-967). The requirement for informed consent was waived because of the retrospective nature of the study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hong, S.K., Jin, XL., Suh, S. et al. Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma. World J Surg 46, 197–206 (2022). https://doi.org/10.1007/s00268-021-06308-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-021-06308-9